Nie M et al. [23] showed that NETs promote tumor growth and dissemination based on TLR9 agonistic activity exerted on lymphoma cells, and Demers M et al. [26] described that primary tumors grow slower in PAD4-deficient mice with LLC lung adenocarcinomas. Here, TLR9 is linked to lymphoma.